What is the current Oyster Point Pharma market capitalization?
The current market capitalization of Oyster Point Pharma is 290.83 M USD.
Oyster Point Pharma Market capitalization 2024
Oyster Point Pharma Market capitalization
290.83 M USD
Ticker
OYST
ISIN
US69242L1061
WKN
A2PTTE
In 2024, Oyster Point Pharma's market cap stood at 290.83 M USD, a -9.45% increase from the 321.19 M USD market cap in the previous year.
The Oyster Point Pharma Market capitalization history
| YEAR | REVENUE (undefined USD) | GROSS MARGIN (%) | NET INCOME (undefined USD) |
|---|---|---|---|
| 2026e | 1.16 | 1,98 | - |
| 2025e | 0.48 | 4,84 | - |
| 2024e | 0.19 | 12,12 | - |
| 2023e | 0.1 | 23,45 | - |
| 2022e | 0.03 | 79,99 | - |
| 2021 | 0.02 | 93,79 | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | - | - | - |
Oyster Point Pharma Aktienanalyse
What does Oyster Point Pharma do?
Oyster Point Pharma Inc is a biopharmaceutical company focused on the development and commercialization of innovative therapies for eye diseases. The company is headquartered in the San Francisco Bay Area and was founded in 2015. History: Oyster Point Pharma was founded by an experienced team of biologists and pharmaceutical experts. The company was supported by venture capital financing from leading venture capitalists. The founders' goal was to develop innovative therapies for eye diseases. In 2017, the company introduced a pipeline of therapies for various eye diseases based on the stimulation of tear flow, corneal nerves, and neurons. Since then, the company has expanded its pipeline and continues to invest significantly in the research and development of innovative therapies. Business model: Oyster Point Pharma has developed an innovative business model based on the development of therapies for eye diseases. The company utilizes its proprietary technology platform to identify new molecular targets and develop effective therapeutic options. The company works closely with leading scientists and clinics to develop and validate its pipeline of therapies. The company's goal is to develop innovative therapies for eye diseases that help patients improve their vision and quality of life. Segments: Oyster Point Pharma focuses on developing innovative therapies for eye diseases. The company currently has three main products in its pipeline: OC-01, OC-02, and OC-03. OC-01 is a nasal spray based on the stimulation of tear flow. The product is currently in phase 3 clinical development for the treatment of patients with dry eye. Treatment with OC-01 is intended to increase the production and flow of tear fluid, thus relieving symptoms such as dryness, itching, and pain. OC-02 is a gel based on the stimulation of corneal nerves. The product is currently in phase 2 clinical development for the treatment of patients with neurotrophic keratitis. Treatment with OC-02 is intended to promote the regeneration of corneal nerves and accelerate the healing of the cornea. OC-03 is a nasal spray based on the stimulation of neurons in the nasal and oral areas. The product is currently in the preclinical development phase for the treatment of patients with acute glaucoma and has not yet been approved for use in humans. Products: Oyster Point Pharma currently has three main products in its pipeline: OC-01, OC-02, and OC-03. These products aim to develop innovative therapies for various eye diseases. The products utilize proprietary technologies to selectively stimulate tear flow, corneal nerves, and neurons. By developing these innovative therapies, the company aims to improve the vision and quality of life of patients. Summary: Oyster Point Pharma is an innovative biopharmaceutical company focused on the development of therapies for eye diseases. The company has developed a proprietary technology platform for the identification of new molecular targets and the development of effective therapeutic options. The company currently has three main products in its pipeline, aiming to develop innovative therapies for various eye diseases. The company's goal is to develop innovative therapies for eye diseases that help patients improve their vision and quality of life. Oyster Point Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring Oyster Point Pharma's Market Capitalization
Oyster Point Pharma's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Oyster Point Pharma's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Oyster Point Pharma's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Oyster Point Pharma’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Oyster Point Pharma stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Oyster Point Pharma.
How has the market capitalization of Oyster Point Pharma developed in recent years?
The market capitalization of Oyster Point Pharma has increased/decreased by -9.45% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Oyster Point Pharma?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Oyster Point Pharma?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Oyster Point Pharma have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Oyster Point Pharma pay?
Over the past 12 months, Oyster Point Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Oyster Point Pharma is expected to pay a dividend of 0 USD.
What is the dividend yield of Oyster Point Pharma?
The current dividend yield of Oyster Point Pharma is .
When does Oyster Point Pharma pay dividends?
Oyster Point Pharma pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Oyster Point Pharma?
Oyster Point Pharma paid dividends every year for the past 0 years.
What is the dividend of Oyster Point Pharma?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Oyster Point Pharma located?
Oyster Point Pharma is assigned to the 'Health' sector.
Wann musste ich die Aktien von Oyster Point Pharma kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Oyster Point Pharma from 7/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/4/2024.
When did Oyster Point Pharma pay the last dividend?
The last dividend was paid out on 7/4/2024.
What was the dividend of Oyster Point Pharma in the year 2023?
In the year 2023, Oyster Point Pharma distributed 0 USD as dividends.
In which currency does Oyster Point Pharma pay out the dividend?
The dividends of Oyster Point Pharma are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Oyster Point Pharma
Our stock analysis for Oyster Point Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Oyster Point Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Oyster Point Pharma Revenue
- Oyster Point Pharma Net Income
- Oyster Point Pharma P/E
- Oyster Point Pharma P/S
- Oyster Point Pharma EBIT
- Oyster Point Pharma Dividend
- Oyster Point Pharma Stocks
- Oyster Point Pharma Market capitalization
- Oyster Point Pharma Debt
- Oyster Point Pharma Liabilities
- Oyster Point Pharma Equity
- Oyster Point Pharma AAQS
- Oyster Point Pharma Employees
- Oyster Point Pharma ROE
- Oyster Point Pharma ROA
- Oyster Point Pharma ROCE
